경막하 연피질검사(ECoG) 어레이 이식 및 Minipig의 장기 피질 기록

Executive Industry Relevance

Long-term cortical recording in minipigs using soft subdural ECoG arrays addresses a critical translational gap for neuroprosthetic device validation. This model enables robust preclinical assessment of device safety, biocompatibility, and signal fidelity, supporting predictive confidence for human application. The approach strengthens portfolio decision-making at the interface of device discovery and regulatory advancement.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables functional interrogation of cortical network activity in a large animal model.
• Supports biological de-risking for novel neuroprosthetic designs prior to clinical translation.
• Provides quantitative benchmarks for device-induced neural responses and tissue integration.

Screening & Assay Development

• Facilitates standardized, reproducible electrophysiological recordings over extended periods.
• Delivers high-resolution, quantitative readouts for device performance and safety metrics.
• Prepares validated animal models for downstream device screening and comparative studies.

Translational & Preclinical Research

• Aligns preclinical safety and efficacy data with regulatory expectations for human neuroprosthetic trials.
• Enables longitudinal monitoring of device-tissue interactions and inflammatory responses.
• Supports risk-adjusted advancement of cortical device candidates toward clinical evaluation.

Pipeline & Workflow Integration

This method integrates into the preclinical validation continuum, bridging device discovery, functional screening, and translational safety assessment.

• Discovery Biology: Provides a platform for hypothesis-driven testing of device impact on cortical function and connectivity.
• Screening: Offers reproducible, quantitative electrophysiological and electrochemical outputs for device comparison.
• Analytics: Enables longitudinal impedance tracking and imaging-based tissue analysis to inform device optimization.
• Translational Research: Delivers biosafety and efficacy data required for regulatory submissions and clinical trial readiness.
• Enterprise Reuse: Establishes a scalable, adaptable model for diverse neuroprosthetic and cortical device pipelines.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in device safety, function, and integration.
• Operational Value: Standardizes chronic implantation and monitoring workflows for reproducibility and scalability.
• Strategic Value: Informs go/no-go decisions and reduces late-stage biological risk for device portfolios.
• Portfolio Impact: Enables risk-adjusted prioritization and advancement of neurotechnology assets.

Implementation Considerations

• Requires surgical expertise in large animal neurosurgery and chronic device implantation.
• Demands access to MRI, X-ray, and electrophysiological recording infrastructure.
• Necessitates cross-team standardization of surgical, imaging, and analytical protocols.
• Adaptable to other large animal models with procedural modifications as needed.
• Careful animal selection and perioperative management are critical to avoid confounding complications.

Biopharma FAQs